Related references
Note: Only part of the references are listed.Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C
Matteo Vidali et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
Rami Moucari et al.
GASTROENTEROLOGY (2008)
Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3
Hossein Poustchi et al.
JOURNAL OF HEPATOLOGY (2008)
Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis
E. Tsochatzis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Adipokines and insulin resistance in chronic hepatitis C
Emmanuel Tsochatzis et al.
HEPATOLOGY (2007)
Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: A comparative approach with genotype 1 chronic hepatitis C
E. Tsochatzis et al.
DIGESTIVE AND LIVER DISEASE (2007)
Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy
Marcello Persico et al.
HEPATOLOGY (2007)
Post-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver disease
G. Svegliati-Baroni et al.
GUT (2007)
Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines
Ian Homer Y. Cua et al.
HEPATOLOGY (2007)
An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study
Spilios Manolakopoulos et al.
BMC GASTROENTEROLOGY (2007)
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis C
O. Lo Iacono et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity
George V. Papatheodoridis et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2007)
Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors
Emmanuel Tsochatzis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Defective hepatic response to interferon and activation of suppressor of cytokine signaling 3 in chronic hepatitis C
Ying Huang et al.
GASTROENTEROLOGY (2007)
Serum apoptotic caspase activity as marker of disease severity in chronic hepatitis C (CH-C) or non-alcoholic fatty liver disease (NAFLD)
G. V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2007)
Race, insulin resistance and hepatic steatosis in chronic hepatitis C
Hari S. Conjeevaram et al.
HEPATOLOGY (2007)
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis
Elisabetta Bugianesi et al.
HEPATOLOGY (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The evolving role of leptin and adiponectin in chronic liver diseases
Emmanuel Tsochatzis et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-α in chronic hepatitis C patients
E. Durante-Mangoni et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Insulin resistance and HCV: Will new knowledge modify clinical management?
Francesco Negro
JOURNAL OF HEPATOLOGY (2006)
Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD
Hellan Kang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Non-alcoholic steatohepatitis and metabolic syndrome
Mariana Machado et al.
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2006)
Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis
GV Papatheodoridis et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis
Silvia Mirandola et al.
GASTROENTEROLOGY (2006)
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data
Gioacchino Leandro et al.
GASTROENTEROLOGY (2006)
Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1
MJ Walsh et al.
GUT (2006)
Nonalcoholic fatty liver disease: From steatosis to cirrhosis
GC Farrell et al.
HEPATOLOGY (2006)
Peroxisome proliferator-activated receptor-alpha and -gamma rnRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection
A De Gottardi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Hepatic steatosis and insulin resistance: Does etiology make a difference?
A Lonardo et al.
JOURNAL OF HEPATOLOGY (2006)
Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C
C Camma et al.
HEPATOLOGY (2006)
Adiponectin and its receptors in patients with chronic hepatitis C
JR Jonsson et al.
JOURNAL OF HEPATOLOGY (2005)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis
G Musso et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Review article: hepatic steatosis and insulin resistance
A Lonardo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
S Jimba et al.
DIABETIC MEDICINE (2005)
Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C
CJ Liu et al.
JOURNAL OF HEPATOLOGY (2005)
Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C
L Fartoux et al.
GUT (2005)
Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy
R D'Souza et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The natural history of nonalcoholic fatty liver disease: A population-based cohort study
LA Adams et al.
GASTROENTEROLOGY (2005)
Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection
Zheng-Wen Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation
K Abid et al.
JOURNAL OF HEPATOLOGY (2005)
Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients
M Romero-Gómez et al.
GASTROENTEROLOGY (2005)
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients
A Muzzi et al.
JOURNAL OF HEPATOLOGY (2005)
Impact of steatosis on progression of fibrosis in patients with mild hepatitis C
L Fartoux et al.
HEPATOLOGY (2005)
Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance
Y Shintani et al.
GASTROENTEROLOGY (2004)
Steatosis affects chronic hepatitis C progression in a genotype specific way
L Rubbia-Brandt et al.
GUT (2004)
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
VT Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
G Donati et al.
GUT (2004)
Relative contribution of iron burden, HFE mutation and insulin resistance to fibrosis in nonalcoholic fatty liver
E Bugianesi et al.
HEPATOLOGY (2004)
Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3
T Kawaguchi et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes
S Aytug et al.
HEPATOLOGY (2003)
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
JM Hui et al.
GASTROENTEROLOGY (2003)
Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C
T Poynard et al.
HEPATOLOGY (2003)
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
G Marchesini et al.
HEPATOLOGY (2003)
Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients
J Westin et al.
JOURNAL OF HEPATOLOGY (2002)
Steatosis in chronic hepatitis C: Relative contributions of obesity, diabetes mellitus, and alcohol
A Monto et al.
HEPATOLOGY (2002)
Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection
JM Hui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men
A Seppälä-Lindroos et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes
B Vozarova et al.
DIABETES (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion:: a model of viral-related steatosis
G Perlemuter et al.
FASEB JOURNAL (2002)
High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis
V Paradis et al.
HEPATOLOGY (2001)
Liver steatosis in chronic hepatitis C:: a morphological sign suggesting infection with HCV genotype 3
L Rubbia-Brandt et al.
HISTOPATHOLOGY (2001)
Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese
JB Dixon et al.
GASTROENTEROLOGY (2001)
Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
LE Adinolfi et al.
HEPATOLOGY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Hepatitis C virus induced hypobetalipoproteinemia:: a possible mechanism for steatosis in chronic hepatitis C
L Serfaty et al.
JOURNAL OF HEPATOLOGY (2001)
Share Paper
